Table 2 Descriptive characteristics of the available study population who underwent CT analysis
Group | SUBJECTS (n = 10) | EMPHYSEMA (n = 21) | CONTROLS (n = 16) | ||||||
|---|---|---|---|---|---|---|---|---|---|
Age, years | 72.6 | ± | 7.2 | 67.1 | ± | 6.0 | 69.8 | ± | 8.7 |
Height, cm | 168.4 | ± | 10.5 | 168.2 | ± | 5.8 | 167.1 | ± | 6.4 |
BMI, kg/mm2 | 22.2 | ± | 1.9* | 22.0 | ± | 3.2‡‡ | 26.0 | ± | 3.4 |
BSA, mm2 | 1.7 | ± | 0.2 | 1.7 | ± | 0.1 | 1.8 | ± | 0.2 |
VC, %pred | 118.9 | ± | 10.0** | 122.9 | ± | 8.8 ‡‡ | 99.6 | ± | 14.1 |
FVC, %pred | 114.7 | ± | 9.9* | 119.2 | ± | 8.0 †† | 95.2 | ± | 13.0 |
FEV1, %pred | 106.8 | ± | 8.6 | 105.0 | ± | 6.3 | 101.7 | ± | 11.3 |
FEV1/FVC, % | 67.7 | ± | 2.1** | 65.8 | ± | 3.1 ‡‡ | 79.6 | ± | 4.2 |
PEFR, %pred | 94.4 | ± | 14.8** | 104.8 | ± | 10.0 | 114.9 | ± | 18.4 |
MMF, %pred | 51.7 | ± | 8.1** | 44.2 | ± | 5.5 ‡‡ | 80.2 | ± | 19.9 |
V50/V25 | 4.5 | ± | 1.9 | 4.6 | ± | 1.3 | 4.0 | ± | 1.2 |
ATI | 3.5 | ± | 3.8 | 3.0 | ± | 1.9 | 4.2 | ± | 2.4 |
MMF/FVC | 0.39 | ± | 0.05** †† | 0.34 | ± | 0.04 ‡‡ | 0.75 | ± | 0.17 |